Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates

Thomas G. Havranek, Terri L. Ashmeade, Maria Afanador, Jane D. Carver

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Antenatal MgSO 4 administration is used extensively as a tocolytic agent and to treat preeclampsia. Various effects on the fetus and newborn have been reported, and MgSO 4 has well-documented vasoactive effects. Objective: To determine if antenatal MgSO 4 administration affects intestinal blood flow velocity in newborn preterm infants. Methods: Peak, mean and end-diastolic velocities in the superior mesenteric artery were measured on day 1 of life. Maternal medical records were reviewed to identify infants whose mothers had been administered MgSO 4 for preterm labor or preeclampsia within 24 h of delivery. Result: Fifty-six infants were studied: 27 were exposed and 29 were not exposed to antenatal MgSO 4. Mean birth weight (1,371 ± 349 and 1,401 ± 469 g, respectively), gestational age (29.7 ± 2.0 and 30.0 ± 2.9 weeks, respectively) and infant hemodynamic and clinical variables (other than clinical indication for antenatal MgSO 4 administration) were similar between groups. There were no significant differences between the exposed and unexposed groups in intestinal blood flow velocities. For the exposed group, however, there was a significant negative correlation between mean velocity and the number of hours from birth to the time superior mesenteric artery blood flow velocity measurements were made (p = 0.002); there was no correlation for the unexposed group (p = 0.852). Conclusion: Group mean values indicate that antenatal exposure to MgSO 4 does not significantly affect intestinal blood flow velocity in newborn preterm infants. However, the significant negative relationship between mean blood flow velocity and time from birth to blood flow velocity measurement in exposed infants suggests that there may be measurable effects of MgSO 4 exposure within the hours immediately after birth. Trials that prospectively evaluate the development of intestinal blood flow velocities are needed to further clarify potential effects of antenatal MgSO 4 on the gastrointestinal tract of preterm infants.

Original languageEnglish (US)
Pages (from-to)44-49
Number of pages6
JournalNeonatology
Volume100
Issue number1
DOIs
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

Magnesium Sulfate
Blood Flow Velocity
Mothers
Newborn Infant
Premature Infants
Superior Mesenteric Artery
Parturition
Pre-Eclampsia
Tocolytic Agents
Premature Obstetric Labor
Birth Weight
Gestational Age
Medical Records
Gastrointestinal Tract
Fetus
Hemodynamics

Keywords

  • Blood flow
  • Magnesium sulfate
  • Preeclampsia
  • Preterm infant
  • Splanchnic blood flow
  • Tocolysis

ASJC Scopus subject areas

  • Developmental Biology
  • Pediatrics, Perinatology, and Child Health

Cite this

Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates. / Havranek, Thomas G.; Ashmeade, Terri L.; Afanador, Maria; Carver, Jane D.

In: Neonatology, Vol. 100, No. 1, 06.2011, p. 44-49.

Research output: Contribution to journalArticle

Havranek, Thomas G. ; Ashmeade, Terri L. ; Afanador, Maria ; Carver, Jane D. / Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates. In: Neonatology. 2011 ; Vol. 100, No. 1. pp. 44-49.
@article{5cc9836e927342e186b0298bf43048da,
title = "Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates",
abstract = "Background: Antenatal MgSO 4 administration is used extensively as a tocolytic agent and to treat preeclampsia. Various effects on the fetus and newborn have been reported, and MgSO 4 has well-documented vasoactive effects. Objective: To determine if antenatal MgSO 4 administration affects intestinal blood flow velocity in newborn preterm infants. Methods: Peak, mean and end-diastolic velocities in the superior mesenteric artery were measured on day 1 of life. Maternal medical records were reviewed to identify infants whose mothers had been administered MgSO 4 for preterm labor or preeclampsia within 24 h of delivery. Result: Fifty-six infants were studied: 27 were exposed and 29 were not exposed to antenatal MgSO 4. Mean birth weight (1,371 ± 349 and 1,401 ± 469 g, respectively), gestational age (29.7 ± 2.0 and 30.0 ± 2.9 weeks, respectively) and infant hemodynamic and clinical variables (other than clinical indication for antenatal MgSO 4 administration) were similar between groups. There were no significant differences between the exposed and unexposed groups in intestinal blood flow velocities. For the exposed group, however, there was a significant negative correlation between mean velocity and the number of hours from birth to the time superior mesenteric artery blood flow velocity measurements were made (p = 0.002); there was no correlation for the unexposed group (p = 0.852). Conclusion: Group mean values indicate that antenatal exposure to MgSO 4 does not significantly affect intestinal blood flow velocity in newborn preterm infants. However, the significant negative relationship between mean blood flow velocity and time from birth to blood flow velocity measurement in exposed infants suggests that there may be measurable effects of MgSO 4 exposure within the hours immediately after birth. Trials that prospectively evaluate the development of intestinal blood flow velocities are needed to further clarify potential effects of antenatal MgSO 4 on the gastrointestinal tract of preterm infants.",
keywords = "Blood flow, Magnesium sulfate, Preeclampsia, Preterm infant, Splanchnic blood flow, Tocolysis",
author = "Havranek, {Thomas G.} and Ashmeade, {Terri L.} and Maria Afanador and Carver, {Jane D.}",
year = "2011",
month = "6",
doi = "10.1159/000319049",
language = "English (US)",
volume = "100",
pages = "44--49",
journal = "Neonatology",
issn = "1661-7800",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates

AU - Havranek, Thomas G.

AU - Ashmeade, Terri L.

AU - Afanador, Maria

AU - Carver, Jane D.

PY - 2011/6

Y1 - 2011/6

N2 - Background: Antenatal MgSO 4 administration is used extensively as a tocolytic agent and to treat preeclampsia. Various effects on the fetus and newborn have been reported, and MgSO 4 has well-documented vasoactive effects. Objective: To determine if antenatal MgSO 4 administration affects intestinal blood flow velocity in newborn preterm infants. Methods: Peak, mean and end-diastolic velocities in the superior mesenteric artery were measured on day 1 of life. Maternal medical records were reviewed to identify infants whose mothers had been administered MgSO 4 for preterm labor or preeclampsia within 24 h of delivery. Result: Fifty-six infants were studied: 27 were exposed and 29 were not exposed to antenatal MgSO 4. Mean birth weight (1,371 ± 349 and 1,401 ± 469 g, respectively), gestational age (29.7 ± 2.0 and 30.0 ± 2.9 weeks, respectively) and infant hemodynamic and clinical variables (other than clinical indication for antenatal MgSO 4 administration) were similar between groups. There were no significant differences between the exposed and unexposed groups in intestinal blood flow velocities. For the exposed group, however, there was a significant negative correlation between mean velocity and the number of hours from birth to the time superior mesenteric artery blood flow velocity measurements were made (p = 0.002); there was no correlation for the unexposed group (p = 0.852). Conclusion: Group mean values indicate that antenatal exposure to MgSO 4 does not significantly affect intestinal blood flow velocity in newborn preterm infants. However, the significant negative relationship between mean blood flow velocity and time from birth to blood flow velocity measurement in exposed infants suggests that there may be measurable effects of MgSO 4 exposure within the hours immediately after birth. Trials that prospectively evaluate the development of intestinal blood flow velocities are needed to further clarify potential effects of antenatal MgSO 4 on the gastrointestinal tract of preterm infants.

AB - Background: Antenatal MgSO 4 administration is used extensively as a tocolytic agent and to treat preeclampsia. Various effects on the fetus and newborn have been reported, and MgSO 4 has well-documented vasoactive effects. Objective: To determine if antenatal MgSO 4 administration affects intestinal blood flow velocity in newborn preterm infants. Methods: Peak, mean and end-diastolic velocities in the superior mesenteric artery were measured on day 1 of life. Maternal medical records were reviewed to identify infants whose mothers had been administered MgSO 4 for preterm labor or preeclampsia within 24 h of delivery. Result: Fifty-six infants were studied: 27 were exposed and 29 were not exposed to antenatal MgSO 4. Mean birth weight (1,371 ± 349 and 1,401 ± 469 g, respectively), gestational age (29.7 ± 2.0 and 30.0 ± 2.9 weeks, respectively) and infant hemodynamic and clinical variables (other than clinical indication for antenatal MgSO 4 administration) were similar between groups. There were no significant differences between the exposed and unexposed groups in intestinal blood flow velocities. For the exposed group, however, there was a significant negative correlation between mean velocity and the number of hours from birth to the time superior mesenteric artery blood flow velocity measurements were made (p = 0.002); there was no correlation for the unexposed group (p = 0.852). Conclusion: Group mean values indicate that antenatal exposure to MgSO 4 does not significantly affect intestinal blood flow velocity in newborn preterm infants. However, the significant negative relationship between mean blood flow velocity and time from birth to blood flow velocity measurement in exposed infants suggests that there may be measurable effects of MgSO 4 exposure within the hours immediately after birth. Trials that prospectively evaluate the development of intestinal blood flow velocities are needed to further clarify potential effects of antenatal MgSO 4 on the gastrointestinal tract of preterm infants.

KW - Blood flow

KW - Magnesium sulfate

KW - Preeclampsia

KW - Preterm infant

KW - Splanchnic blood flow

KW - Tocolysis

UR - http://www.scopus.com/inward/record.url?scp=78650875203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650875203&partnerID=8YFLogxK

U2 - 10.1159/000319049

DO - 10.1159/000319049

M3 - Article

C2 - 21212694

AN - SCOPUS:78650875203

VL - 100

SP - 44

EP - 49

JO - Neonatology

JF - Neonatology

SN - 1661-7800

IS - 1

ER -